Retinol-binding protein 4 (RBP4) protein expression is increased in omental adipose tissue of severely obese patients

Obesity

Volumn 18, Issue 4, 2010, Pages 663-666

  Kelly, Karen R ^a,b   Kashyap, Sangeeta R ^a   O'Leary, Valerie B ^a   Major, Jennifer ^a   Schauer, Philip R ^a   Kirwan, John P ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE TRANSPORTER 4; INSULIN; PLASMA PROTEIN; PLASMA RETINOL BINDING PROTEIN; RBP4 PROTEIN, HUMAN;

ARTICLE; BODY MASS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INTRAABDOMINAL FAT; MALE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OMENTUM; PHYSIOLOGY; SIGNAL TRANSDUCTION; STOMACH BYPASS;

ADIPOSITY; BLOOD GLUCOSE; BLOOD PROTEINS; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GLUCOSE TRANSPORTER TYPE 4; HUMANS; INSULIN; INTRA-ABDOMINAL FAT; MALE; OBESITY; OMENTUM; RETINOL-BINDING PROTEINS, PLASMA; SIGNAL TRANSDUCTION;

EID: 77950188623     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.328     Document Type: Article

References (20)

1. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14: 173-194.
2. Bourey RE, Kohrt WM, Kirwan JP et al. Relationship between glucose tolerance and glucose-stimulated insulin response in 65-year-olds. J Gerontol 1993;48:M122-M127.
3. Kohrt WM, Kirwan J P, Staten MA et al. Insulin resistance in aging is related to abdominal obesity. Diabetes 1993;42:273-281.
4. Yang Q, Graham TE, Mody N et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362.
5. Graham TE, Yang Q, Blüher M et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563.
6. Klöting N, Graham TE, Berndt J et al. Serum retinol-binding protein is more highly expressed in visceral than in subcutaneous adipose tissue and is a marker of intra-abdominal fat mass. Cell Metab 2007;6:79-87.
7. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature 2001;414:799-806.
8. Bandyopadhyay GK, Yu JG, Ofrecio J, Olefsky JM. Increased p85/55/50 expression and decreased phosphotidylinositol 3-kinase activity in insulin-resistant human skeletal muscle. Diabetes 2005;54:2351-2359.
9. Kirwan J P, Varastehpour A, Jing M et al. Reversal of insulin resistance postpartum is linked to enhanced skeletal muscle insulin signaling. J Clin Endocrinol Metab 2004;89:4678-4684.
10. Shepherd PR, Kahn BB. Glucose transporters and insulin action\implications for insulin resistance and diabetes mellitus. N Engl J Med 1999;341:248-257.
11. Ziouzenkova O, Orasanu G, Sharlach M et al. Retinaldehyde represses adipogenesis and diet-induced obesity. Nat Med 2007;13:695-702.
12. Hotamisligil GS, Budavari A, Murray D, Spiegelman BM. Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes. Central role of tumor necrosis factor-α. J Clin Invest 1994;94:1543-1549.
13. Mauvais-Jarvis F, Ueki K, Fruman DA et al. Reduced expression of the murine p85α subunit of phosphoinositide 3-kinase improves insulin signaling and ameliorates diabetes. J Clin Invest 2002;109:141-149.
14. Janke J, Engeli S, Boschmann M et al. Retinol-binding protein 4 in human obesity. Diabetes 2006;55:2805-2810.
15. Yao-Borengasser A, Varma V, Bodles AM et al. Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone. J Clin Endocrinol Metab 2007;92: 2590-2597.
16. Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P. Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action. Diabetes 2009;58:54-60.
17. Weisberg S P, McCann D, Desai M et al. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003;112: 1796-1808.
18. Yuan M, Konstantopoulos N, Lee J et al. Reversal of obesity-and diet-induced insulin resistance with salicylates or targeted disruption of Ikκβ. Science 2001;293:1673-1677.
19. Vázquez-Vela ME, Torres N, Tovar AR. White adipose tissue as endocrine organ and its role in obesity. Arch Med Res 2008;39:715-728.
20. Szalowska E, Elferink MG, Hoek A, Groothuis GM, Vonk RJ. Resistin is more abundant in liver than adipose tissue and is not up-regulated by lipopolysaccharide. J Clin Endocrinol Metab 2009;94:3051-3057.